JPRN-UMIN000010443已完成2 期
Randomized phase II trial of Carboplatin plus weekly nab-Paclitaxel versus Cisplatin plus Gemcitabine in patients with chemo-naive stage IIIB/IV or postoperative recurrent squamous cell lung cancer - NJLCG1302 CBDCA + weekly nab-PTX vs CDDP + GEM for SQ-NSCLC patients
orth Japan Lung Cancer Study Group0 个研究点目标入组 71 人开始时间: 2013年4月22日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 71
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Previous treatment with gemcitabine and paclitaxel as adjuvant chemotherapy 2) Active double cancer 3) Symptomatic brain metastasis 4) Pleural and peritoneal effusion likely to require surgical intervention, or pericardial effusion 5) Superior vena cava syndrome 6) Grade 2 or higher peripheral neuropathy 7) Radiographically confirmed interstitial pneumonitis or pulmonary fibrosis 8) Severe concurrent disease (Ischemic heart disease requiring treatment, arrhythmia, cardiac infarction within 6 months before enrollment, hepatic failure, hemorrhagic peptic ulcer, poorly controlled diabetes) 9)History of Severe drug allergies. 10) Pregnant females, possibly pregnant females, females wishing to become pregnant and nursing mothers. Males that are currently attempting to produce a pregnancy. 11) Physician concludes that the patient's participation in this trial is inappropriate.
研究者
相似试验
进行中（未招募）
不适用
A randomised phase II pilot trial of carboplatin compared to docetaxel for patients with metastatic genetic breast cancer.Ensayo piloto randomizado en fase II que compara carboplatino y docetaxel en pacientes con cáncer de mama genético metastásico. - BRCA TrialEUCTR2004-001496-20-ESniversity College London
已完成
不适用
Randomized phase II trial comparing carboplatin plus irinotecan with carboplatin plus amrubicine for extensive disease small-cell lung cancerSmall-cell lung cancerJPRN-UMIN000008970orth-Japan lung cancer group70
已完成
不适用
A Phase II Study of biweekly Carboplatin, nab-paclitaxel, and concurrent Thoracic radiation therapy for Patients with local advanced Non-small cell Lung CancerJPRN-UMIN000023802Hirosaki University28
进行中（未招募）
1 期
A randomized phase II trial of standard carboplatin-based chemotherapy with or without panitumumab in platinum-sensitive recurrent ovarian cancerPlatinum-sensitive recurrent ovarian cancerMedDRA version: 19.1Level: LLTClassification code 10033131Term: Ovarian carcinomaSystem Organ Class: 100000004864EUCTR2010-018849-59-DEGMIHO Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie mbH
已完成
不适用
A phase II study of concurrent weekly carboplatin and paclitaxel combined with definitive radiotherapy for advanced-stage cervical cancer.terine cervical cancerJPRN-UMIN000017232Osaka University Hospital80